US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MATTHEWS EMERGING MARKETS DISCOVERY ACTIVE ETF

30.65

-0.0464-0.15%

Post-market: 30.700.0467+0.15%16:10 EDT

Volume:724

Turnover:22.24K

Market Cap:22.07M

PE:- -

High:30.70

Open:30.70

Low:30.65

Close:30.70

52wk High:32.57

52wk Low:24.64

Shares:720.00K

Float Shares:720.00K

Volume Ratio:0.42

T/O Rate:0.10%

Dividend:0.72

Dividend Rate:2.34%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), Legend Biotech (LEGN) and Sagimet Biosciences, Inc. Class A (SGMT)

U.S. Stocks on the MOVE-Duke Energy, Sea, Cardinal Health

GenScript Biotech Announces Legend Biotech Form 6-K for Q2 Ended June 30, 2026

Legend Biotech Rises After Second Quarter Results Beat Estimates

Legend Biotech Shares Rise 4.1% Premarket After Q2 Revenue Beat

THOMSON REUTERS

Legend Biotech Q2 Revenue Beats Estimates on Commercial Expansion

Legend Biotech Q2 FY26 Turns to Net Income of $33.2 Million; Revenue Rises 51.9% to $387.5 Million Year over Year

Legend Biotech Corporation - Carvykti Net Trade Sales Increase 50% in Q2 2026 to $657 Mln

THOMSON REUTERS

Legend Biotech Corporation Q2 Adjusted EPS USD 0.16 VS. Ibes Estimate USD 0.07

THOMSON REUTERS

Legend Biotech Reports Second Quarter 2026 Results and Recent Highlights

THOMSON REUTERS

After Multiple Bearish Catalysts, Legend Biotech's Stock Halved in Two Months: Value Trap or Bargain Opportunity?

Top News Today/Canada: Barrick Settles Newmont Dispute, Clearing Way to List Its Gold Assets

Legend Biotech Corporation Expected to Post Earnings of 7 Cents a Share - Earnings Preview

Legend Biotech Interim CEO Alan Bash Files Initial Beneficial Ownership Statement

Legend Biotech (LEGN) CEO Exit Raises Questions, Is The Stock Still Cheap?

Simply Wall St.

Legend Biotech to Host Investor Call on Second-quarter 2026 Results

Legend Biotech Corp : Raymond James Cuts Target Price to $58 from $86

THOMSON REUTERS

Buy Rating Reiterated as Strong CARVYKTI Momentum and Attractive Valuation Support Unchanged $65 Price Target

Under the Radar: Legend Stock Tumbles After CEO's Abrupt Departure

Legend Biotech's In Vivo CAR-T Cell Therapy Data Validates Approach, RBC Capital Markets Says

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/MEMS/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MEMS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEMS\",,,,,undefined,":{"symbol":"MEMS","market":"US","secType":"STK","nameCN":"MATTHEWS EMERGING MARKETS DISCOVERY ACTIVE ETF","latestPrice":30.6533,"timestamp":1788292800000,"preClose":30.6997,"halted":0,"volume":724,"hourTrading":{"tag":"盘后","latestPrice":30.7,"preClose":30.6533,"latestTime":"16:10 EDT","volume":6,"amount":183.9198,"timestamp":1788293404407,"change":0.0467,"changeRate":0.001523,"amplitude":0},"delay":0,"changeRate":-0.0015114154209975486,"floatShares":720000,"shares":720000,"eps":0,"marketStatus":"Not Yet Opened","change":-0.0464,"latestTime":"09-01 16:00:00 EDT","open":30.7,"high":30.7,"low":30.6533,"amount":22242,"amplitude":0.001521,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788336000000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":30.6997,"sharesOutstanding":720000,"nav":30.959,"aum":22290288.22,"dividendRate":0.023378,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":30.7,"preClose":30.6533,"latestTime":"16:10 EDT","volume":6,"amount":183.9198,"timestamp":1788293404407,"change":0.0467,"changeRate":0.001523,"amplitude":0},"volumeRatio":0.415757},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEMS\",,,,,undefined,":{"symbol":"MEMS","floatShares":720000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.415757,"shares":720000,"dividePrice":0.7166,"high":30.7,"amplitude":0.001521,"preClose":30.6997,"low":30.6533,"week52Low":24.6357,"pbRate":"--","week52High":32.565,"institutionHeld":0,"latestPrice":30.6533,"eps":0,"divideRate":0.023378,"volume":724,"delay":0,"ttmEps":0,"open":30.7,"prevYearClose":25.545,"prevWeekClose":30.8858,"prevMonthClose":30.6997,"prevQuarterClose":31.7347,"fiveDayClose":31.0946,"twentyDayClose":30.5915,"sixtyDayClose":30.1038},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MEMS\",params:#limit:5,,,undefined,":[{"date":"2025-12-17","symbol":"MEMS","amount":0.71648,"announcedDate":"2025-12-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-17","defaultRemindTime":1765981800000,"name":"MATTHEWS EMERGING MARKETS DISCOVERY ACTIVE ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-22","payableDate":"2025-12-17","currency":"USD","dateTimestamp":1765947600000,"payDate":"2025-12-22"},{"date":"2024-12-18","symbol":"MEMS","amount":0.33495,"announcedDate":"2024-12-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-18","defaultRemindTime":1734532200000,"name":"MATTHEWS EMERGING MARKETS DISCOVERY ACTIVE ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-23","payableDate":"2024-12-18","currency":"USD","dateTimestamp":1734498000000,"payDate":"2024-12-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MEMS\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-18","recordDate":"2024-12-18","paymentDate":"2024-12-23","value":0.33495,"currency":"USD"},{"executeDate":"2025-12-17","recordDate":"2025-12-17","paymentDate":"2025-12-22","value":0.71648,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MEMS\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MEMS\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658791274","title":"Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), Legend Biotech (LEGN) and Sagimet Biosciences, Inc. Class A (SGMT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658791274","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658791274?lang=en_us&edition=fundamental","pubTime":"2026-08-12 01:40","pubTimestamp":1786470008,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Immunic (IMUX), Legend Biotech (LEGN) and Sagimet Bi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-immunic-imux-legend-biotech-legn-and-sagimet-biosciences-inc-class-a-sgmt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-immunic-imux-legend-biotech-legn-and-sagimet-biosciences-inc-class-a-sgmt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","CANC","IMUX","SGMT","LEGN","BK4505","LU0128526141.USD","LABU","BK4581","XLV","BK4139","XBI","MEMS","BK4137","HCSG","BK4585","LU0029874061.USD","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658130309","title":"U.S. Stocks on the MOVE-Duke Energy, Sea, Cardinal Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2658130309","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658130309?lang=en_us&edition=fundamental","pubTime":"2026-08-11 21:21","pubTimestamp":1786454464,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Duke Energy, Sea, Cardinal HealthAugust 11 (Reuters)-Wall Street's main indexes were poised to open higher on Tuesday as investors welcomed a report suggesting the United ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL6N4480DV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861220207.SGD","LU1880398554.USD","BK4175","LU2125910500.SGD","AIS","ESPO","LU0109394709.USD","LU2089985449.USD","LU1242518857.USD","BK4212","BK4085","LU2238330802.EUR","SG9999002604.SGD","LU0052756011.USD","LU2065171402.SGD","BK4077","UAA","LU2177674079.SGD","SG9999014484.SGD","IE0001KFT4U8.USD","SG9999002414.USD","LU0516422440.USD","BK4218","IE00B2B36J28.USD","WSPC","CWII","MARS","SG9999001440.SGD","LU1621767737.EUR","LU0472753341.HKD","GAP","LU0175139822.USD","NURE","BK4120","ASTS","BK4503","LU0499858438.USD","BBH","ASTN","BK4181","LU0069063385.USD","LU0154236417.USD","IE00B4R5TH58.HKD","STTK","LU0081259029.USD","BK4225","FXG","LU1861220033.SGD","BK4094","DIPR","VG","LU2362540622.SGD","SG9999002406.SGD","HERO","JAN","CRWU","LU0516423174.USD","NETG","LU2290526834.HKD","LU1621767810.EUR","SG9999002950.SGD","BK4187","SFD","RVMD","LU0289960550.SGD","FUTY","LU0979878070.USD","HIYY","IE000M9KFDE8.USD","LU1861215975.USD","RKLB","CAH","ONON","LU0889566641.SGD","LU2286300806.USD","IE0009355771.USD","LU1880398471.USD","FDNI","BK4116","BK4554","BK4585","LU0264606111.USD","LU1804176565.USD","BK4560","BK4581","LU0589944569.HKD","LU1621768206.USD","LU2265009873.SGD","BK4089","LU2152927971.USD","RKLX","NUKX","LU0511384066.AUD","CORD","BK4196","CLOU","LU2543165471.USD","LU0823038988.USD","BK4146","LU0792757196.USD","FPWR","LU1983299246.USD","LU0719512351.SGD","LU1585245621.USD","WBTN","ACIU","LU0210637038.USD","IE0009354923.USD","LEGN","LU0345776255.USD","LU2362541273.HKD","WARP","BK4213","BK4615","LU0251143029.SGD","LU0348788117.USD","LU2384288077.EUR","CANC","IE00B29SXK94.USD","BSP","IE00BD6J9T35.USD","TRUU","BK4524","HMYY","LU0572939691.SGD","SG9999006266.SGD","THNR","BK4141","LU2362541513.USD","LU1621768115.EUR","LU0345775950.USD","IE0031814969.USD","BK4081","LU0289739343.SGD","IE0002141913.USD","LU1839390173.USD","LU1244550577.SGD","SG9999002679.SGD","LU0057025933.USD","SG9999005177.SGD","LU0128525689.USD","SIMO","BK4548","LU0572940350.SGD","LU0006061336.USD","LU0640476718.USD","LU0082616367.USD","LU0516422952.EUR","XITK","LU0516422366.SGD","XLU","BK4607","LU0889565916.HKD","TTWO","LU1267930227.SGD","DUK","BK4526","BK4139","LU0441851309.USD","AHR","BK4564","LU1244550494.USD","HIMZ","ORBX","BK4202","LU1280957306.USD","LU1861217088.USD","LU2065170008.USD","LU2360107671.USD","MEMS","NET","JXI","LU0072461881.USD","UPW","LU1244550221.USD","HEAL","LU0061475181.USD","LU1323610961.USD","LU0532188223.SGD","LU2008162690.USD","BK4613","BK4023","LU0211328371.USD","LU0274383776.USD","CRWG","LU0737861269.HKD","LU1267930490.SGD","SG9999002620.SGD","SG9999013478.USD","LTL","LU2463526074.USD","LU1242518931.SGD","BK4566","FSPC","LU0048573645.USD","SG9999014492.USD","IE00BJJMRZ35.SGD","LU1571399168.USD","VPU","XLC","LU1267930813.SGD","LU2360107168.USD","BK4547","URAN","IE0034224299.USD","HIMS","PTH","SG9999001135.SGD","LU2125910849.SGD","LU0072462343.USD","LU0320765992.SGD","LU0499858602.USD","LU1861558580.USD","LU0211327993.USD","UFO","SG9999013460.SGD","LU1430594728.SGD","LU0162691827.USD","IDU","RKLZ","XDAT","IE00BJT1NW94.SGD","LU2065169927.USD","SGXZ58947870.SGD","BK4551","BYND","BK4505","IE00BFTCPJ56.SGD","CRWV","GLAM","LU0310799852.SGD","LU0261945553.USD","BK4588","BK4007","WTRE","BK4535","RSPC","RHP","LU2045819591.USD","HIMY","BNGE","LU1770036033.HKD","NETX","SE","SG9999013486.USD","BK4220","SG9999004360.SGD","IE00B29SXL02.USD","BK4606","CWVX","LU1861559042.SGD","IDNA","LU0516423091.SGD","LU2065171311.SGD","LU1048588211.SGD","NERD","LU0289961442.SGD","MEDI","LU0310800965.SGD","LU0823039010.USD","ASTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658990626","title":"GenScript Biotech Announces Legend Biotech Form 6-K for Q2 Ended June 30, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2658990626","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658990626?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:08","pubTimestamp":1786450126,"startTime":"0","endTime":"0","summary":"GenScript Biotech announces Legend Biotech Form 6-K for Q2 ended June 30, 2026GenScript Biotech announced the posting of Legend Biotech’s Form 6-K covering financial results for the second quarter end","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL30HtKm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000320264.USD","HK0000306701.USD","BK1141","BK4505","BK4585","BK4588","HK0000306685.HKD","HK0000320223.HKD","BK1583","BK1576","MEMS","LEGN","CANC","01548","MEDI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658921869","title":"Legend Biotech Rises After Second Quarter Results Beat Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2658921869","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658921869?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:15","pubTimestamp":1786446952,"startTime":"0","endTime":"0","summary":"BUZZ-Legend Biotech rises after second quarter results beat estimates** Shares of drugmaker Legend BiotechLEGN.Oclimbs 5.1% to $21.70 premarket** LEGN posts Q2 revenue of $387.5 million — above analys","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL4N4480QO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEGN","MEDI","BK4585","CANC","BK4139","MEMS","BK4588","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658992947","title":"Legend Biotech Shares Rise 4.1% Premarket After Q2 Revenue Beat","url":"https://stock-news.laohu8.com/highlight/detail?id=2658992947","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658992947?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:15","pubTimestamp":1786446949,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nFWN4480NL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4505","LEGN","MEDI","MEMS","BK4139","CANC","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658699254","title":"Legend Biotech Q2 Revenue Beats Estimates on Commercial Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2658699254","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658699254?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:09","pubTimestamp":1786446570,"startTime":"0","endTime":"0","summary":"Legend Biotech Q2 revenue beats estimates on commercial expansionOverviewCell therapy company's Q2 revenue rose sharply, beating analyst expectationsAdjusted EPS for Q2 beat analyst expectations, refl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL1N4480DK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","LU1670711040.USD","BK4559","LEGN","BK4534","LU1718418525.SGD","LU0096364046.USD","LU1670711123.USD","BK4007","LU1670710661.SGD","LU0321505439.SGD","LU1261432733.SGD","LU1585245621.USD","BBIO","LU2596442595.SGD","IE00BFTCPJ56.SGD","LU1868837300.USD","FTXH","LU0237698245.USD","LU0868494617.USD","LU2242652126.USD","LU1074936037.SGD","BK4588","LU0985481810.HKD","LU1670710588.SGD","BK4585","IE0009355771.USD","LU1983299246.USD","LU1868836914.USD","LU1291159041.SGD","LU1323610961.USD","PROK","LU0456855351.SGD","BK4139","LU1989771016.USD","LU0267386448.USD","LU1571399168.USD","LU1868836757.USD","IE0002141913.USD","MEDI","MEMS","LU0321505868.SGD","LU0225284248.USD","LU2242646821.SGD","LU0114720955.EUR","IHE","LU1032466523.USD","CANC","BMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658992582","title":"Legend Biotech Q2 FY26 Turns to Net Income of $33.2 Million; Revenue Rises 51.9% to $387.5 Million Year over Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2658992582","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658992582?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:07","pubTimestamp":1786446478,"startTime":"0","endTime":"0","summary":"Legend Biotech Q2 FY26 turns to net income of $33.2 million; revenue rises 51.9% to $387.5 million year over yearLegend Biotech posted IFRS net income of $33.2 million, swinging from a loss, on total ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL9tmbRj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEGN","MEDI","BK4585","CANC","BK4139","MEMS","BK4588","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658947969","title":"Legend Biotech Corporation - Carvykti Net Trade Sales Increase 50% in Q2 2026 to $657 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2658947969","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658947969?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:00","pubTimestamp":1786446004,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nPLX818D8T:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4505","MEDI","BK4585","CANC","LEGN","BK4588","MEMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658299405","title":"Legend Biotech Corporation Q2 Adjusted EPS USD 0.16 VS. Ibes Estimate USD 0.07","url":"https://stock-news.laohu8.com/highlight/detail?id=2658299405","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658299405?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:00","pubTimestamp":1786446004,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nPLX818D8T:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDI","LEGN","BK4585","BK4139","BK4505","MEMS","CANC","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658199442","title":"Legend Biotech Reports Second Quarter 2026 Results and Recent Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2658199442","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658199442?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:00","pubTimestamp":1786446004,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nTUA47MYCS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4505","LEGN","MEDI","MEMS","BK4139","CANC","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183064015","title":"After Multiple Bearish Catalysts, Legend Biotech's Stock Halved in Two Months: Value Trap or Bargain Opportunity?","url":"https://stock-news.laohu8.com/highlight/detail?id=1183064015","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183064015?lang=en_us&edition=fundamental","pubTime":"2026-08-11 18:11","pubTimestamp":1786443066,"startTime":"0","endTime":"0","summary":"A sharp 40% rally that seemed to signal a new valuation upswing instead marked the final chapter of the previous rebound. After spending two months pushing its share price back to a high of $37.50,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159934","USG","159831","XME","BGLD","DUST","IAUI","SGDM","PICK","BK4207","UGL","GLL","YGLD","GLTR","GOLY","BK4585","FGDL","BK4505","MGCmain","SGCmain","GBUG","GDX","CEF","GLDY","518880","BK4504","FAAR","GDXU","DBC","MEMS","MEDI","SHNY","BK4139","BK4588","GLD","RING","SGOL","DULL","GCmain","AAAU","IGLD","JNUG","BTGD","DGP","DZZ","JDST","GDXY","LEGN","KGLD","GLDM","GOAU","PALL","BAR","QOmain","NUGT","PHYS","BK4535","GDXD","GDXJ","SGUmain","UYM","1OZmain","CANC","OUNZ","IAU","IAUM","DGZ","BEGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658951980","title":"Top News Today/Canada: Barrick Settles Newmont Dispute, Clearing Way to List Its Gold Assets","url":"https://stock-news.laohu8.com/highlight/detail?id=2658951980","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658951980?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:33","pubTimestamp":1786393980,"startTime":"0","endTime":"0","summary":"HEADLINESBarrick Mining Settles Newmont Nevada Dispute for $1.95 Billion, Clearing Way to List its Gold AssetsBarrick Mining has settled a long-standing dispute with rival Newmont over their Nevada op","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LVWD","CANC","TCRX","LU0154236417.USD","BK4175","VSTS","APRE","LU0240877869.USD","VERA","IMNN","NVRI","TNGX","ARMK","IMUX","IE00B3S45H60.SGD","MIDD","DRIO","BWEN","MASS","MEDI","ACCS","SLSN","SG9999001440.SGD","LEGN","WHF","BK4023","BK4179","JBI","RXT","CRIS","GHI","MEMS","REFI","SLAB","STIM","CAH","BK4109","BK4127","BK4123","HBIO","OBIO","AVXL","BK4167","AMTM","FLOC","PESI","SYPR","BSIN","DOMH","KLXE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657286366","title":"Legend Biotech Corporation Expected to Post Earnings of 7 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2657286366","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657286366?lang=en_us&edition=fundamental","pubTime":"2026-08-08 01:24","pubTimestamp":1786123446,"startTime":"0","endTime":"0","summary":"Legend Biotech Corporation <LEGN.OQ> expected to post earnings of7cents a share - Earnings PreviewLegend Biotech CorporationLEGN.OQLEGN.Ois expected to  show a rise in quarterly revenue when it report","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL8N44428V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEGN","BK4139","MEDI","MEMS","BK4585","BK4505","BK4588","CANC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656302298","title":"Legend Biotech Interim CEO Alan Bash Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2656302298","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656302298?lang=en_us&edition=fundamental","pubTime":"2026-08-04 05:02","pubTimestamp":1785790953,"startTime":"0","endTime":"0","summary":"Legend Biotech interim CEO Alan Bash files initial beneficial ownership statementLegend Biotech interim CEO Alan Bash filed an initial Form 3 disclosing 30,234 ordinary shares, including 13,092 RSUs v","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL6RBBSR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEMS","BK4588","LEGN","BK4139","BK4505","CANC","MEDI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655336101","title":"Legend Biotech (LEGN) CEO Exit Raises Questions, Is The Stock Still Cheap?","url":"https://stock-news.laohu8.com/highlight/detail?id=2655336101","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655336101?lang=en_us&edition=fundamental","pubTime":"2026-07-31 10:21","pubTimestamp":1785464509,"startTime":"0","endTime":"0","summary":"Legend Biotech (LEGN) is back in focus after CEO and board member Ying Huang, Ph.D., resigned on July 24, 2026. CARVYKTI business head Alan Bash is stepping in as Interim CEO.\nSee our latest analysis for Legend Biotech.\nLegend Biotech's share price has come under pressure despite its cell therapy focus, with the 30 day share price return down 34.04% and the 1 year total shareholder return down 51.24%, suggesting momentum has faded as investors reassess execution risk after the CEO change.\nIf...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-legn/legend-biotech/news/legend-biotech-legn-ceo-exit-raises-questions-is-the-stock-s","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-legn/legend-biotech/news/legend-biotech-legn-ceo-exit-raises-questions-is-the-stock-s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XBI","BK4588","BK4139","CANC","BK4505","BK4581","LEGN","MEMS","MEDI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654004836","title":"Legend Biotech to Host Investor Call on Second-quarter 2026 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2654004836","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654004836?lang=en_us&edition=fundamental","pubTime":"2026-07-28 20:07","pubTimestamp":1785240461,"startTime":"0","endTime":"0","summary":"Legend Biotech to host investor call on second-quarter 2026 resultsLegend Biotech scheduled an investor conference call at 8:00 a.m. ET on Aug. 11, 2026 to review second-quarter 2026 results.Live webcast access via .Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Legend Biotech Corporation published the original content used to generate this news brief on July 28, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nNDL4LDKKr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","CANC","BK4505","BK4139","MEMS","MEDI","BK4585","LEGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654210009","title":"Legend Biotech Corp : Raymond James Cuts Target Price to $58 from $86","url":"https://stock-news.laohu8.com/highlight/detail?id=2654210009","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654210009?lang=en_us&edition=fundamental","pubTime":"2026-07-28 19:34","pubTimestamp":1785238492,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nFWN43U10V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","MEMS","BK4585","CANC","BK4505","BK4139","MEDI","LEGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654003233","title":"Buy Rating Reiterated as Strong CARVYKTI Momentum and Attractive Valuation Support Unchanged $65 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2654003233","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654003233?lang=en_us&edition=fundamental","pubTime":"2026-07-28 18:15","pubTimestamp":1785233738,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Mitchell Kapoor reiterated a Buy rating on Legend Biotech today and set a price target of $65.00. Mitchell Kapoor has given...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-reiterated-as-strong-carvykti-momentum-and-attractive-valuation-support-unchanged-65-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-reiterated-as-strong-carvykti-momentum-and-attractive-valuation-support-unchanged-65-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4505","BK4588","XBI","BK4139","CANC","LEGN","MEMS","MEDI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654044945","title":"Under the Radar: Legend Stock Tumbles After CEO's Abrupt Departure","url":"https://stock-news.laohu8.com/highlight/detail?id=2654044945","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654044945?lang=en_us&edition=fundamental","pubTime":"2026-07-28 01:01","pubTimestamp":1785171660,"startTime":"0","endTime":"0","summary":"Shares of Legend Biotech fell 14% Monday after the company announced that CEO Ying Huang stepped down and left the board. Legend said in a regulatory filing that Huang's resignation was not the result of a disagreement with the company, but didn't say anything more about why he left.Huang didn't immediately respond to messages seeking comment. The board named Alan Bash-president of the unit responsible for Legend's main drug-as interim CEO while it searches for a permanent successor.Legend, based in New Jersey, sold $1.9 billion of that drug, Carvykti, last year. The therapy is made by removing a patient's own immune cells, reprogramming them in a lab to attack cancer and infusing them back into the body. Legend co-develops and sells Carvykti with Johnson & Johnson under a 2017 deal. The companies split profits equally outside China, while Legend keeps 70% of profits inside China.Oppenheimer analyst Kostas Biliouris said the leadership change was a mixed signal for investors. Huang had","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Under the Radar: Legend Stock Tumbles After CEO's Abrupt Departure","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","LEGN","BK4588","BK4585","CANC","MEDI","MEMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654104947","title":"Legend Biotech's In Vivo CAR-T Cell Therapy Data Validates Approach, RBC Capital Markets Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2654104947","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654104947?lang=en_us&edition=fundamental","pubTime":"2026-07-27 23:32","pubTimestamp":1785166365,"startTime":"0","endTime":"0","summary":"Legend Biotech's  data from its in vivo CAR-T cell therapy program clearly validates the approach, RBC Capital Markets said in a note Monday.The investment firm said the market is not fully appreciating Legend Biotech's potential with the program, with the company giving back most of its share gains.RBC said the potential for additional follow-up data this year and the fact that in vivo's profile should enable higher peak potential could drive Legend's shares higher.The company could reach the market as soon as 2029 if they move expediently with larger phase 1 dose expansion cohorts, enabling a $3 billion opportunity in non-Hodgkin lymphoma alone, according to the note.RBC Capital Markets retained an outperform rating on the stock, but lowered its price target to $59 from $63.Shares of the company were down more than 14% in Monday trading.Price: 18.97, Change: -3.26, Percent Change: -14.65","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LEGN","BK4230","BK4505","XBI","LU0128525929.USD","BK4585","BK4022","LU0029864427.USD","MEDI","BK4139","BK4207","LU0310800379.SGD","GSIB","MEMS","LU1267930573.SGD","BK4581","BK4588","LU0708994859.HKD","CAR","CANC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":57,"code":"91000000","status":"200"}]}}